98 related articles for article (PubMed ID: 12890489)
1. PI3K inhibitors changed the p53-induced response of Saos-2 cells from growth arrest to apoptosis.
Ren S; Gao C; Zhang L; Koike K; Tsuchida N
Biochem Biophys Res Commun; 2003 Aug; 308(1):120-5. PubMed ID: 12890489
[TBL] [Abstract][Full Text] [Related]
2. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria.
Tsuruta F; Masuyama N; Gotoh Y
J Biol Chem; 2002 Apr; 277(16):14040-7. PubMed ID: 11842081
[TBL] [Abstract][Full Text] [Related]
3. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.
Karpinich NO; Tafani M; Rothman RJ; Russo MA; Farber JL
J Biol Chem; 2002 May; 277(19):16547-52. PubMed ID: 11864976
[TBL] [Abstract][Full Text] [Related]
4. Redox regulation of PI3K/Akt and p53 in bovine aortic endothelial cells exposed to hydrogen peroxide.
Niwa K; Inanami O; Yamamori T; Ohta T; Hamasu T; Kuwabara M
Antioxid Redox Signal; 2003 Dec; 5(6):713-22. PubMed ID: 14588144
[TBL] [Abstract][Full Text] [Related]
5. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
6. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
8. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis.
Gao CF; Ren S; Zhang L; Nakajima T; Ichinose S; Hara T; Koike K; Tsuchida N
Exp Cell Res; 2001 Apr; 265(1):145-51. PubMed ID: 11281652
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PI 3 kinase/Akt-dependent Bad phosphorylation in Toxoplasma gondii-mediated inhibition of host cell apoptosis.
Quan JH; Cha GH; Zhou W; Chu JQ; Nishikawa Y; Lee YH
Exp Parasitol; 2013 Apr; 133(4):462-71. PubMed ID: 23333591
[TBL] [Abstract][Full Text] [Related]
11. LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.
Gong C; Liao H; Wang J; Lin Y; Qi J; Qin L; Tian LQ; Guo FJ
Asian Pac J Cancer Prev; 2012; 13(7):3103-7. PubMed ID: 22994717
[TBL] [Abstract][Full Text] [Related]
12. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose.
Kang BP; Urbonas A; Baddoo A; Baskin S; Malhotra A; Meggs LG
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F1013-24. PubMed ID: 12876069
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
[TBL] [Abstract][Full Text] [Related]
15. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
Curnock AP; Knox KA
Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
[TBL] [Abstract][Full Text] [Related]
16. Bcl-x(S) induces an NGF-inhibitable cytochrome c release.
Lindenboim L; Schlipf S; Kaufmann T; Borner C; Stein R
Exp Cell Res; 2004 Jul; 297(2):392-403. PubMed ID: 15212942
[TBL] [Abstract][Full Text] [Related]
17. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
18. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria.
Deng Y; Wu X
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12050-5. PubMed ID: 11050235
[TBL] [Abstract][Full Text] [Related]
19. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
Moon DO; Lee KJ; Choi YH; Kim GY
Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
[TBL] [Abstract][Full Text] [Related]
20. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
Luu Y; Bush J; Cheung KJ; Li G
Exp Cell Res; 2002 Jun; 276(2):214-22. PubMed ID: 12027451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
